10 research outputs found
Recommended from our members
Endocrine disruptors and obesity
The purpose of this review is to summarise current evidence that some environmental chemicals may be able to interfere in endocrine regulation of energy metabolism and adipose tissue structure. Recent findings demonstrate that such endocrine disrupting chemicals, termed “obesogens”, can promote adipogenesis and cause weight gain. This includes compounds to which the human population is exposed in daily life through their use in pesticides/herbicides, industrial and household products, plastics, detergents, flame retardants and ingredients in personal care products. Animal models and epidemiological studies have shown that an especially sensitive time for exposure is in utero or the neonatal period. In summarising the actions of obesogens, it is noteworthy that as their structures are mainly lipophilic, their ability to increase fat deposition has the added consequence of increasing the capacity for their own retention. This has the potential for a vicious spiral not only of increasing obesity but also increasing retention of other lipophilic pollutant chemicals with an even broader range of adverse actions. This might offer an explanation as to why obesity is an underlying risk factor for so many diseases including cancer
Molecular Mechanisms of Action of BPA
Bisphenol A (BPA) exposure has been associated with serious endocrine-disrupting effects in humans and wildlife. Toxicological
and epidemiological studies evidenced that BPA increases body mass index and disrupts normal cardiovascular physiology by
interfering with endogenous hormones in rodents, nonhuman primates, and cell culture test systems. The BPA concentration
derived from these experiments were used by government regulatory agencies to determine the safe exposure levels of BPA in
humans. However, accumulating literature in vivo and in vitro indicate that at concentrations lower than that reported in toxicological
studies, BPA could elicit a different endocrine-disrupting capacity. To further complicate this picture, BPA effects rely on
several and diverse mechanisms that converge upon endocrine and reproductive systems. If all or just few of these mechanisms
concur to the endocrine-disrupting potential of low doses of BPA is at present still unclear. Thus, taking into account that the
incidence and/or prevalence of health problems associated with endocrine disruption have increased worldwide, the goal of the
present review is to give an overview of the many mechanisms of BPA action in order to decipher whether different mechanisms
are at the root of the effect of low dose of BPA on endocrine system
Concept mapping One-Carbon Metabolism to model future ontologies for nutrient–gene–phenotype interactions
Advances in the development of bioinformatic tools continue to improve investigators’ ability to interrogate, organize, and derive knowledge from large amounts of heterogeneous information. These tools often require advanced technical skills not possessed by life scientists. User-friendly, low-barrier-to-entry methods of visualizing nutrigenomics information are yet to be developed. We utilized concept mapping software from the Institute for Human and Machine Cognition to create a conceptual model of diet and health-related data that provides a foundation for future nutrigenomics ontologies describing published nutrient–gene/polymorphism–phenotype data. In this model, maps containing phenotype, nutrient, gene product, and genetic polymorphism interactions are visualized as triples of two concepts linked together by a linking phrase. These triples, or “knowledge propositions,” contextualize aggregated data and information into easy-to-read knowledge maps. Maps of these triples enable visualization of genes spanning the One-Carbon Metabolism (OCM) pathway, their sequence variants, and multiple literature-mined associations including concepts relevant to nutrition, phenotypes, and health. The concept map development process documents the incongruity of information derived from pathway databases versus literature resources. This conceptual model highlights the importance of incorporating information about genes in upstream pathways that provide substrates, as well as downstream pathways that utilize products of the pathway under investigation, in this case OCM. Other genes and their polymorphisms, such as TCN2 and FUT2, although not directly involved in OCM, potentially alter OCM pathway functionality. These upstream gene products regulate substrates such as B12. Constellations of polymorphisms affecting the functionality of genes along OCM, together with substrate and cofactor availability, may impact resultant phenotypes. These conceptual maps provide a foundational framework for development of nutrient–gene/polymorphism–phenotype ontologies and systems visualization